This Forecast Opportunity provides information relating to an upcoming grant opportunity scheduled for 2022. Please note that some details (e.g. submission dates) may change when the Grant Opportunity is published on GrantConnect.
The European Joint Programme on Rare Diseases (EJP RD) brings over 130 institutions from 35 countries together to create a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation.
As part of the EJP RD, international organisations have joined forces to carry out a joint call for proposals for transnational cooperative research projects in the field of rare diseases. The list of participating funding organisations is listed on the EJP RD website.
The objectives of the 2022 MRFF Joint Transnational Call grant opportunity are to provide grants of financial assistance to support Australian medical research and medical innovation projects that develop new analytic tools and pathways to accelerate diagnosis and diagnostic monitoring (including undiagnosed cases) of rare diseases.
The intended outcome of the research is to improve the health and wellbeing of Australians by improving diagnosis and providing better treatment options for those with a rare disease.
To be competitive for funding, applicants must propose to conduct research that delivers against the objectives as described in the grant guidelines.
For this grant opportunity, up to $1.0 million of funding is available in 2022-23 to support the Australian component of the research as outlined in the 2022 MRFF Joint Transnational Call grant guidelines.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.
Further information on the Medical Research Future Fund (MRFF) is available from the Department of Health’s MRFF website.